Equities

GMO Research & AI Inc

GMORF:PNK

GMO Research & AI Inc

Actions
  • Price (USD)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year GMO Research & AI Inc's net income fell -13.77% from 356.39m to 307.31m despite relatively flat revenues. A contributing factor has been an increase in the selling, general and administrative costs as a percentage of sales from 39.30% to 41.07%.
Gross margin49.90%
Net profit margin3.14%
Operating margin4.25%
Return on assets5.56%
Return on equity7.61%
Return on investment7.94%
More ▼

Cash flow in JPYView more

In 2023, GMO Research & AI Inc increased its cash reserves by 14.37%, or 167.75m. The company earned 475.49m from its operations for a Cash Flow Margin of 9.29%. In addition the company used 131.49m on investing activities and also paid 187.50m in financing cash flows.
Cash flow per share157.70
Price/Cash flow per share15.96
Book value per share1,175.02
Tangible book value per share984.62
More ▼

Balance sheet in JPYView more

GMO Research & AI Inc uses little debt in its capital structure as supported by a debt to capital ratio of 0.35%.
Current ratio2.61
Quick ratio2.53
Total debt/total equity0.0035
Total debt/total capital0.0035
More ▼

Growth rates in JPY

SmartText is unavailable
Div yield(5 year avg)3.39%
Div growth rate (5 year)20.80%
Payout ratio (TTM)126.24%
EPS growth(5 years)16.11
EPS (TTM) vs
TTM 1 year ago
-41.83
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.